Market Tracker

04/29 6:45pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

1.42
Delayed Data
As of Apr 29
 -0.04 / -2.74%
Today’s Change
1.08
Today|||52-Week Range
4.11
-13.41%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close1.46
Today’s open1.48
Day’s range1.41 - 1.49
Volume76,525
Average volume (3 months)127,384
Market cap$42.1M
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-12.82%
Earnings growth (this year)+22.16%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.41

Competitors

 Today’s
change
Today’s
% change
AVDXAvant Diagnostics In...+0.02+4.74%
CGIXCancer Genetics Inc-0.04-1.48%
ERBERBA Diagnostics Inc-0.08-7.27%
TTHITransition Therapeut...-0.06-7.29%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 6, 2016
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$0.00
Annual profit (last year)-$20.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Chief Medical Officer &
Director
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts